Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet

Nutrition

Volumn 23, Issue 10, 2007, Pages 709-718

  Larkin, Theresa A ^a,b   Price, William E ^a,b   Astheimer, Lee B ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b Australian Government Australian Research Council   (Australia)

Author keywords

Bioavailability; Daidzein; Genistein; Isoflavone; Probiotic; Resistant starch

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE; PREBIOTIC AGENT; PROBIOTIC AGENT; STARCH; YOGHURT;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; MALE; METABOLISM; MICROFLORA; POSTMENOPAUSE; PRIORITY JOURNAL; SOYBEAN; URINALYSIS;

AGED; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; GENISTEIN; HUMANS; INTESTINES; ISOFLAVONES; MALE; MIDDLE AGED; PROBIOTICS; SOYBEANS; STARCH; YOGURT;

EID: 34548654735     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.06.010     Document Type: Article

References (63)

1. Winter J., and Bokkenheuser V. Bacterial metabolism of natural and synthetic sex hormones undergoing enterohepatic circulation. J Steroid Biochem 27 (1987) 1145-1149
2. Rowland I., Wiseman H., Sanders T., Adlercreutz H., and Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 27 (1999) 304-308
3. Adlercreutz H. Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis. Proc Soc Exp Biol Med 217 (1998) 241-246
4. Xu X., Wang H., Murphy P., and Hendrich S. Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women. J Nutr 130 (2000) 798-801
5. Izumi T., Piskula M., Osawa S., Obata A., Tobe K., Saito M., et al. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 130 (2000) 1695-1699
6. Setchell K., Brown N., Desai P., Zimmer-Nechemias L., Wolfe B., Brashear W., et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131 (2001) 1362S-1375S
7. Steer T., Johnson I., Gee J., and Gibson G. Metabolism of the soyabean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics. Br J Nutr 90 (2003) 635-642
8. Xu X., Harris K., Wang H., and Murphy P. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125 (1995) 2307-2315
9. Turner N., Thomson B., and Shaw I. Bioactive Isoflavones in functional foods: the importance of gut microflora on bioavailability. Nutr Rev 61 (2003) 204-213
10. Gibson G. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 80 (1998) S209-S212
11. O'Sullivan D. Screening of intestinal microflora for effective probiotic bacteria. J Agric Food Chem 49 (2001) 1751-1760
12. Cummings J., Roberfroid M., Andersson H., Barth C., Ferro-Luzzi A., Ghoos Y., et al. A new look at dietary carbohydrate: chemistry, physiology and health. Eur J Clin Nutr 51 (1997) 417-423
13. Gomes A., and Malcata F. Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci Technol 10 (1999) 139-157
14. Gibson G. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129 (1999) 1438S-1441S
15. Englyst H., Kingman S., Hudson G., and Cummings J. Measurement of resistant starch in vitro and in vivo. Br J Nutr 75 (1996) 749-755
16. Topping D., and Clifton P. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81 (2001) 1031-1064
17. Brown I., Wang X., and Conway P. Sticky and selective starches. Microbiol Aust (1999) 18-19 Sept
18. Silvi S., Cresci R., and Rowland I. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol 86 (1999) 521-530
19. Decroos K., Vanhemmens S., Cattoir S., Boon N., and Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol 183 (2005) 45-55
20. Arora A., Nair M., and Strasburg G. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 356 (1998) 133-141
21. Mitchell J., Gardner P., McPhail D., Morrice P., Collins A., and Duthie G. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360 (1998) 142-148
22. Atkinson C., Frankenfeld C., and Lampe J. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 230 (2005) 155-170
23. Gamache P., and Acworth I. Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection. Proc Soc Exp Biol Med 217 (1998) 274-280
24. Larkin T. Soy isoflavone bioavailability-effects of probiotic and prebiotic consumption and oil supplementation (PhD thesis) (2005), University of Wollongong, Wollongong
25. Shimakawa Y., Matsubara S., Yuki N., Ikeda M., and Ishikawa F. Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Int J Food Microbiol 81 (2003) 131-136
26. Shin H., Lee J., Pestka J., and Ustunol Z. Viability of bifidobacteria in commercial dairy products during refrigerated storage. J Food Protect 63 (2000) 327-331
27. Chen R., Wu J., Lee S., Huang A., and Wu H. Increase of intestinal bifidobacterium and suppression of coliform bacteria with short-term yogurt ingestion. J Dairy Sci 82 (2000) 2308-2314
28. Cummings J., and Macfarlane G. Role of intestinal bacteria in nutrient metabolism. JPEN 21 (1997) 357-365
29. Dunne C., O'Mahony L., Murphy L., Thornton G., Morrissey D., O'Halloran S., et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73 (2001) 386S-392S
30. Rolfe R. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130 (2000) 396S-402S
31. Gorbach S., and Goldin B. Nutrition and the gastrointestinal microflora. Nutr Rev 50 (1992) 378-381
32. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 73 (2001) 399S-405S
33. Crittenden R., Morris L., Harvey M., Tran L., Mitchell H., and Playne M. Selection of a Bifidobacterium strain to complement resistant starch in a synbiotic yoghurt. J Appl Microbiol 90 (2001) 268-278
34. Hove H., Norgaard H., and Mortensen P. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr 53 (1999) 339-350
35. Kailasapathy K., and Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78 (2000) 80-88
36. Bartram H., Scheppach W., Gerlach S., and Ruckdeschel G. Does yogurt enriched with Bifidobacterium longum affect microbiology and fecal metabolites in healthy subjects?. Am J Clin Nutr 59 (1994) 428-432
37. Guerin-Danan C., Chabanet C., Pedone C., Popot F., Vaissade P., Bouley C., et al. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Clin Nutr 67 (1998) 111-117
38. Marteau P., Pochart P., Flourie B., Pellier P., Santos L., Desjeux J., and Rambaud J. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 52 (1990) 685-688
39. Nettleton J., Greany K., Thomas W., Wangen K., Adlercreutz H., and Kurzer M. Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 134 (2004) 1998-2003
40. Hylla S., Gostner A., Dusel G., Anger H., Bartram H., Christl S., et al. Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. Am J Clin Nutr 67 (1998) 136-142
41. Cummings J., Beatty E., Kingman S., Bingham S., and Englyst H. Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr 75 (1996) 733-747
42. Phillips J., Muir J., Burkett A., Lu Z., Jones G., O'Dea K., and Young G. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. Am J Clin Nutr 62 (1995) 121-130
43. Schwiertz A., Lehmann U., Jacobasch G., and Blaut M. Influence of resistant starch on the SCFA production and cell counts of butyrate-producing Eubacterium spp. in the human intestine. J Appl Microbiol 93 (2002) 157-162
44. Wang X., Brown I., Khaled D., Mahoney M., Evans A., and Conway P. Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amolymaize) starch granules. J Appl Microbiol 93 (2002) 390-397
45. Tsangalis D., Ashton J., McGill A., and Shah N. Enzymic transformation of isoflavone phytoestrogens in soymilk by β-glucosidase-producing bifidobacteria. J Food Sci 67 (2002) 3104-3113
46. Chang Y., and Nair M. Metabolism of daidzein and genistein by intestinal bacteria. J Nat Prod 58 (1995) 1892-1896
47. Kim D., Yu K., Bae E., and Han M. Metabolism of puerarin and daidzein by human intestinal bacteria and their relation to in vitro cytotoxicity. Biol Pharm Bull 21 (1998) 628-630
48. Ling W., Korpela R., Mykkanen H., Salminen S., and Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 124 (1994) 18-23
49. Rowland I., Mallett A., and Wise A. The effect of diet on the mammalian gut flora and its metabolic activities. CRC Crit Rev Toxicol 16 (1985) 31-103
50. Bouhnik Y., Vahedi K., Achour L., Attar A., Salfati J., Pochart P., et al. J. Short-chain fructo-oligosacchharide administration dose-dependently increases fecal Bifidobacteria in healthy humans. J Nutr 129 (1999) 113-116
51. Cummings J., Macfarlane G., and Englyst H. Prebiotic digestion and fermentation. Am J Clin Nutr 73 (2001) 415S-420S
52. Uehara M., Ohta A., Sakai K., Suzuki K., Watanabe S., and Adlercreutz H. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats. J Nutr 131 (2001) 787-795
53. Lampe J., Skor H., Li S., Wahala K., Howald W., and Chen C. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131 (2001) 740-744
54. Lampe J., Karr S., Hutchins A., and Slavin J. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 217 (1998) 335-339
55. Slavin J., Karr S., Hutchins A., and Lampe J. Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am J Clin Nutr 68 (1998) 1492S-1495S
56. Ueno T., and Uchiyama S. Identification of the specific intestinal bacteria capable of metabolising soy isoflavone to equol. Ann Nutr Metab 45 (2001) 114 [abstract]
57. Atkinson C., Berman S., Humbert O., and Lampe J. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 134 (2004) 596-599
58. Rowland I. Optimal nutrition: fibre and phytochemicals. Proc Nutr Soc 58 (1999) 415-419
59. Brown I., Wang X., Topping D., Playne M., and Conway P. High amylose maize starch as a versatile prebiotic for use with probiotic bacteria. Food Aust 50 (1998) 602-609
60. Akaza H., Miyanaga N., Takashima N., Naito S., Hirao Y., Tsukamoto A., et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34 (2004) 86-89
61. Zhang Y., Wang G., Song T., Murphy P., and Hendrich S. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity. J Nutr 129 (1999) 957-962
62. Hendrich S., Wang G., Xu X., Tew B., Wang H., and Murphy P. Human bioavailability of soy bean isoflavones: influences of diet, dose, time, and gut microflora. In: Shibamoto T., Terao J., and Osawa T. (Eds). Functional foods for disease prevention (1998), ACS, Washington, DC 150-156
63. Rafii F., Davis C., Park M., Heinze T., and Beger R. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Arch Microbiol 180 (2003) 11-16